November 18, 2026
Health news, explained with evidence
LIVE

Early Treatment of Eosinophilic Esophagitis May Lower Subsequent Asthma Risk in Children

🧠 AI Analysis 2 min read 👁 3

A recent study suggests that treating young children with eosinophilic esophagitis using dupilumab is linked to a lower risk of developing asthma later.

Early Treatment of Eosinophilic Esophagitis May Lower Subsequent Asthma Risk in Children🧠AI Analysis

Photo: Medical Xpress

Key points

  • What to know: Young children treated for EoE with dupilumab showed a lower subsequent risk of asthma compared to those treated with budesonide.
  • The study analyzed matched health records from 2016 through early 2026 for children aged six and younger.
  • Always talk to a doctor or board-certified allergist for personal medical decisions and treatment choices.

A new study presented at the American College of Allergy, Asthma and Immunology 2026 Annual Scientific Meeting and published in the Annals of Allergy Asthma & Immunology indicates that young children treated for eosinophilic esophagitis (EoE) with dupilumab had a reduced likelihood of developing asthma compared to those receiving budesonide. EoE is an allergic condition causing esophageal inflammation that can hinder eating, provoke vomiting, and impair normal growth in pediatric patients.

This investigation builds upon the clinical concept known as the "allergic march," wherein children frequently develop successive allergic disorders such as eczema, food allergies, and eventually asthma, driven by shared immune signaling pathways. Led by immunologist and study author Kayla Steinberger, M.D., Ph.D., researchers utilized global health records from 2016 to early 2026 to analyze 344 children aged six and younger with EoE who did not have asthma, matching them against 401 peers treated with budesonide.

While the findings suggest that early medical intervention targeting allergic pathways may influence the progression of the allergic march, the observational nature of the research means it shows a link rather than definitive causation. Experts emphasize that further prospective studies following children over time are necessary to confirm these effects. Parents of children diagnosed with EoE should consult a board-certified allergist regarding therapeutic options and remain vigilant for respiratory symptoms such as wheezing or coughing.

Source Medical Xpress — medicalxpress.com/news/2026-11-early-treatment-eosinophilic-esophagitis… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.